Literature DB >> 27881549

Genome Sequence of Corynebacterium pseudotuberculosis Strain XH02 Isolated from a Boer Goat in Xuanhan, China.

Zuoyong Zhou1, Hexian Li2, Mengsi Zhang2, Zhiying Wang2, Rongqiong Zhou2, Shijun Hu2, Xiaoxia Li2, Xinyue Song2, Zheng Zhu2.   

Abstract

We report here the genome sequence of Corynebacterium pseudotuberculosis strain XH02, isolated from a Boer goat in China. The genome consists of 2,357,671 bp, with a 52.18% G+C content, 2,263 coding sequences, 21 rRNAs, 49 tRNAs, and 44 predicted pseudogenes.
Copyright © 2016 Zhou et al.

Entities:  

Year:  2016        PMID: 27881549      PMCID: PMC5122691          DOI: 10.1128/genomeA.01329-16

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Corynebacterium pseudotuberculosis, a pleomorphic, Gram-positive, and facultatively intracellular bacterium, is the etiological agent of caseous lymphadenitis (1). As a zoonotic pathogen, it mainly infects small ruminants, especially sheep and goats (2). It can also infect several other mammalian species, including horses, cattle, pigs, buffaloes, camels, coypus, hedgehogs, as well as humans (3). The diseases caused by C. pseudotuberculosis result in great economic loss because the sheep and goat industries are largely affected in Brazil, Australia, United States, South Africa, India, and China (2, 4–8). With the advantage of high-throughput sequencing, several genome sequences of C. pseudotuberculosis are currently available in the NCBI’s database. However, genome sequences of C. pseudotuberculosis from indigenous species from China have not been reported, even though more than 30 reports of infection in goats, sheep, and camels in China have been recorded (China National Knowledge Infrastructure database). To better understand and enrich the genomic information of a C. pseudotuberculosis isolate from China, we sequenced the genome of C. pseudotuberculosis strain XH02. Strain XH02 was first isolated in Xuanhan, China, from a subcutaneous abscess in the neck of a two-year-old Boer goat. A drug sensitivity test showed XH02 to be highly sensitive to 13 antibacterial agents, including chloromycetin, tetracycline, norfloxacin, minocycline, cefoxitin, clarithromycin, roxithromycin, and ceftriaxone, but completely resistant to nitrofurantoin and furazolidone (7). The genome of C. pseudotuberculosis strain XH02 was sequenced on an Illumina HiSeq 4000 platform after the establishment of a qualified Illumina paired-end library. Raw sequence data were generated by the Illumina base-calling software CASAVA version 1.8.2 (http://support.illumina.com/sequencing/sequencing_software/casava.ilmn). The SeqPrep (https://github.com/jstjohn/SeqPrep) and Sickle (https://github.com/najoshi/sickle) software programs were used to remove contamination reads and conduct read trimming with default parameters to obtain clean data. A total of 9,193,824 clean reads were obtained with an average coverage of 928×. The clean data were used for genome assembly with SOAPdenovo version 2.04 (http://soap.genomics.org.cn) with multiple k-mer parameters. GapCloser software (http://soap.genomics.org.cn) was subsequently applied to fill up the remaining local inner gaps and correct the single-base polymorphism for the final assembly results. The assembly produced 10 scaffolds with an N50 value of 549, 021 bp. Both tRNAs and rRNAs were predicted using tRNAscan-SE version 1.23 (9) and RNAmmer version 1.2 (10), respectively. The genome of C. pseudotuberculosis strain XH02 contains 2,357,671 bp with a G+C content of 52.18%, 2,263 coding sequences, 44 pseudogenes, 21 rRNAs, and 49 tRNAs.

Accession number(s).

The genome sequence obtained with this study was deposited in DDBJ/EMBL/GenBank under the accession number MDWN00000000. The version described in this paper is the first version, MDWN01000000.
  7 in total

1.  tRNAscan-SE: a program for improved detection of transfer RNA genes in genomic sequence.

Authors:  T M Lowe; S R Eddy
Journal:  Nucleic Acids Res       Date:  1997-03-01       Impact factor: 16.971

2.  Rapid detection of Corynebacterium pseudotuberculosis in clinical samples from sheep.

Authors:  Jyoti Kumar; Bhupendra Nath Tripathi; Rajiv Kumar; Ganesh Gangaram Sonawane; Shivendra Kumar Dixit
Journal:  Trop Anim Health Prod       Date:  2013-02-21       Impact factor: 1.559

3.  High seroprevalence of caseous lymphadenitis in Brazilian goat herds revealed by Corynebacterium pseudotuberculosis secreted proteins-based ELISA.

Authors:  N Seyffert; A S Guimarães; L G C Pacheco; R W Portela; B L Bastos; F A Dorella; M B Heinemann; A P Lage; A M G Gouveia; R Meyer; A Miyoshi; V Azevedo
Journal:  Res Vet Sci       Date:  2009-08-07       Impact factor: 2.534

Review 4.  Corynebacterium pseudotuberculosis and its role in ovine caseous lymphadenitis.

Authors:  G J Baird; M C Fontaine
Journal:  J Comp Pathol       Date:  2007-09-10       Impact factor: 1.311

Review 5.  Corynebacterium pseudotuberculosis: microbiology, biochemical properties, pathogenesis and molecular studies of virulence.

Authors:  Fernanda Alves Dorella; Luis Gustavo Carvalho Pacheco; Sergio Costa Oliveira; Anderson Miyoshi; Vasco Azevedo
Journal:  Vet Res       Date:  2006 Mar-Apr       Impact factor: 3.683

Review 6.  Progression of 'OMICS' methodologies for understanding the pathogenicity of Corynebacterium pseudotuberculosis: the Brazilian experience.

Authors:  Fernanda A Dorella; Alfonso Gala-Garcia; Anne C Pinto; Boutros Sarrouh; Camila A Antunes; Dayana Ribeiro; Flavia F Aburjaile; Karina K Fiaux; Luis C Guimarães; Núbia Seyffert; Rachid A El-Aouar; Renata Silva; Syed S Hassan; Thiago L P Castro; Wanderson S Marques; Rommel Ramos; Adriana Carneiro; Pablo de Sá; Anderson Miyoshi; Vasco Azevedo; Artur Silva
Journal:  Comput Struct Biotechnol J       Date:  2013-10-13       Impact factor: 7.271

7.  RNAmmer: consistent and rapid annotation of ribosomal RNA genes.

Authors:  Karin Lagesen; Peter Hallin; Einar Andreas Rødland; Hans-Henrik Staerfeldt; Torbjørn Rognes; David W Ussery
Journal:  Nucleic Acids Res       Date:  2007-04-22       Impact factor: 16.971

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.